X4 Pharmaceuticals XFOR
NASDAQ XFOR
$2.83 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

X4 Pharmaceuticals (XFOR) Price to Sales (2019 - 2026)

Updated

X4 Pharmaceuticals' Price to Sales came in at 37.23 for Q2 2026, compared with 0.46 a year earlier and down 35.7% from the prior quarter.

Analysis

X4 Pharmaceuticals (XFOR) Price to Sales (2019 - 2026) Analysis & Trends

For FY2025, X4 Pharmaceuticals' Price to Sales was 4.82, down 90.2% from FY2024.

  • Going back by year, Price to Sales was 49.07 in FY2024.
  • The five-year range for quarterly Price to Sales is 0.46 (Q2 2025) to 6194.79 (Q2 2024).
  • Business Quant data shows XFOR's Price to Sales at 57.86 (Q1 2026), 4.82 (Q4 2025) and 4.36 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 X4 Pharmaceuticals 357.55 Mn -341.13 Mn 7.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.23
Mar 31, 2026 57.86
Dec 31, 2025 4.82
Sep 30, 2025 4.36
Jun 30, 2025 0.46
Mar 31, 2025 1.31
Dec 31, 2024 49.07
Sep 30, 2024 100.39
Jun 30, 2024 6,194.79
Dec 31, 2020 1,048.46
Sep 30, 2020 1,102.61
Jun 30, 2020 1,507.62
Mar 31, 2020 1,614.19
Sep 30, 2019 1,354.84
API Access

X4 Pharmaceuticals Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=XFOR&period=max&api_key=YOUR_API_KEY